AGARWAL, S.; MEHTA, S. Food and drug administration gives breakthrough: sanctioning of Rezdiffra for non-alcoholic steatohepatitis. International Journal of Advances in Medicine, [S. l.], v. 12, n. 1, p. 155–155, 2024. DOI: 10.18203/2349-3933.ijam20243826. Disponível em: https://www.ijmedicine.com/index.php/ijam/article/view/4152. Acesso em: 24 apr. 2025.